IRWD

Ironwood Pharmaceuticals (IRWD)

Ironwood Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IRWD

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/05/09	20 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/05/09	20 : 00	Business Wire	Ironwood Pharmaceuticals Reports First Quarter 2024 Results	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/05/07	05 : 01	Business Wire	Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/05/01	20 : 30	Business Wire	Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/04/26	05 : 01	Business Wire	Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/03/28	20 : 30	Business Wire	Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/03/09	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/03/08	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/03/07	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/29	20 : 00	Business Wire	Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/23	21 : 30	Business Wire	Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	21 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	21 : 00	Business Wire	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results; Achieves 2023 Financial Guidance	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	11 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	10 : 53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	10 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	10 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	10 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/15	10 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/13	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/10	06 : 13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/10	06 : 11	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/10	06 : 09	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/10	06 : 05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/02/02	06 : 01	Business Wire	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Investor Update Call	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc
2024/01/20	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IRWD	Ironwood Pharmaceuticals Inc